CNS Pharmaceuticals Inc.

1.14
-0.11 (-8.80%)
At close: Apr 03, 2025, 3:59 PM
1.15
0.81%
After-hours: Apr 03, 2025, 06:16 PM EDT

CNS Pharmaceuticals Statistics

Share Statistics

CNS Pharmaceuticals has 2.94M shares outstanding. The number of shares has increased by 0.2% in one year.

Shares Outstanding 2.94M
Shares Change (YoY) 0.2%
Shares Change (QoQ) 30.66%
Owned by Institutions (%) 3.2%
Shares Floating 2.92M
Failed to Deliver (FTD) Shares -
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 1.14M, so 1.98% of the outstanding shares have been sold short.

Short Interest 1.14M
Short % of Shares Out 1.98%
Short % of Float 2%
Short Ratio (days to cover) 0.04

Valuation Ratios

The PE ratio is -0.15 and the forward PE ratio is -0.27. CNS Pharmaceuticals's PEG ratio is 0.

PE Ratio -0.15
Forward PE -0.27
PS Ratio 0
Forward PS null
PB Ratio 0.37
P/FCF Ratio -0.13
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for CNS Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.05.

Current Ratio 3.43
Quick Ratio 3.43
Debt / Equity 0.05
Debt / EBITDA -0.02
Debt / FCF -0.02
Interest Coverage 924.44

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-4.95M
Employee Count 3
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 1.12, so CNS Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.12
52-Week Price Change null%
50-Day Moving Average 3.59
200-Day Moving Average 16.38
Relative Strength Index (RSI) 30.27
Average Volume (20 Days) -

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -14.9M
Net Income -14.86M
EBITDA -14.9M
EBIT -14.87M
Earnings Per Share (EPS) -38.87
Full Income Statement

Balance Sheet

The company has 6.46M in cash and 326.07K in debt, giving a net cash position of 6.14M.

Cash & Cash Equivalents 6.46M
Total Debt 326.07K
Net Cash 6.14M
Retained Earnings -84.42M
Total Assets 7.41M
Working Capital 3.33M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.11M and capital expenditures -4.19K, giving a free cash flow of -17.12M.

Operating Cash Flow -17.11M
Capital Expenditures -4.19K
Free Cash Flow -17.12M
FCF Per Share -44.78
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CNSP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for CNSP.

Price Target $25
Price Target Difference n/a
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Feb 21, 2025. It was a backward split with a ratio of 1:50.

Last Split Date Feb 21, 2025
Split Type backward
Split Ratio 1:50

Scores

Altman Z-Score -21.84
Piotroski F-Score 4